User login
Enter your username and password here in order to log in on the website:
Keywords
- ABPA_Aspergillus
- accompanying diseases
- air-improving devices
- allergy
- animals_pets
- antibiotic therapy
- asthma
- complementary medicine
- covid-19
- diabetes
- diagnostics
- drugs side effects
- drugs under development_genetic therapy
- ENT
- general aspects
- genetics
- health care
- hepatobiliary disease
- hygiene
- i.v.-lines
- inhalation
- lung
- microbiology
- miscellaneous
- modulator therapy
- MRSA
- nutrition and GI problems
- oxygen supplementation_therapy
- physiotherapy
- Pseudomonas aeruginosa
- psychosocial
- public facilities
- recreational activities
- reproduction
- research
- social law
- sport
- swine flu_novel influenza
- transplantation
- travelling
- vaccination
- ventilation
Topics
- Heterozygous mutation F508del with deletion exon 17a and b
- Dear ladies and gentlemen, is there any research about the above mentioned mutations? Could VX770 be also helpful here? What does the above mentioned mutation mean? We have been told that our daughter (1 year) will be with the utmost probability compound heterozygous. Many thanks for your ...
- 10.10.2011
- new clinical trial
- Hello Our physician told us about a new research protocol calling IGY IMPACTT ... from a Swedish laboratory. The treatment is made from egg yolk, to combat Pseudomonas aeruginosa. Can you give me information related to this treatment. Thank you
- 01.09.2011
- G551D and delta F508 mutations
- Hello! My daughter has the above mutations. Can you say something about progression? Could VX770 help? She is six months old. Would an application be too early at this point?
- 04.08.2011
- Efficacy of VX 770
- Dear expert team, I have besides F508del the mutation "FTR del 2,3". In case of the homozygous occurence of F508del, one does already know, that VX 770 is efficient only to a very small extent concerning the nasal potential difference. It is known to me, that there are at the moment no ...
- 01.08.2011
- Good news about the combination VX-770 & VX-809
- Hello, I noticed news about the VX-770 and VX-809 combination for patient with F508del mutation (deltaF508). Unfortunately I am not very strong in English and the automatic translators are not always clear. Here are the sites where I could see the ...
- 12.07.2011
- Crataegus
- Dear CF-team, quite a time ago, the influence of Crataegus on CF had been investigated. However, I cannot find a final conclusive judgment/results in the internet. Can you give me (F508del-mutation heterozygous) some information about this? Best regards and thank you,
- 20.06.2011
- research
- Hello Is it possible to take part, as a patient, in test of Meveol®? when?
- 23.05.2011
- Mannitol
- Hello, Is there information when mannitol (bronchitol®; dry powder for inhalation) will be authorised for the market in Germany and France? Thanks.
- 23.05.2011
- Montelukast (Singulair®)
- Dear expert team, In “CF-Focus” (issue 4, 2006) [German publication] there was a report about a positive study with regards to the effect of Montelukast in CF. Since then, I have not heard anything about it anymore. Do you know why this promising approach has not been pursued? Best ...
- 24.05.2011
- Splicing mutation
- Hello Are they any studies underway for splicing mutations? If yes, what are they? Thank you for your answer.
- 05.05.2011